본문 바로가기
KERD
논문KCI 등재

The Efficacy of Early Scheduled Follow-Up Endoscopic Retrograde Cholangiopancreatography after Common Bile Duct Stone Removal

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Background/Aims: To investigate the effi cacy of early scheduled follow-up endoscopic retrograde cholangiopancreatography (ERCP) after common bile duct (CBD) stone removal. Methods: Patients who underwent endoscopic CBD stone removal and who had at least one risk factor for stone recurrence were enrolled. Six months after complete clearance of the CBD, patients underwent follow-up ERCP at an ambulatory care center, irrespective of symptoms. Results: The incidence of symptoms and cholangitis at follow-up ERCP was signifi cantly lower in Group A (ERCP at 6 months after stone removal) than that in Group B (ERCP at >6 months) (14.3%vs 71.4%, p=0.00; 9.5% vs 33.3%, p=0.02, respectively). However, the recurrence rates of CBD stones were not different between Groups A and B (33.3% vs 47.6%). When comparing the subgroups, Group AR (stone recurrence in Group A)displayed signifi cantly fewer symptoms and lesser cholangitis and spent fewer days in the hospital than did Group BR (stone recurrence in Group B) (21.4% vs 70%, p=0.02; 14.3% vs 60%, p=0.02; 2.43±1.87 vs 6.10±3.35, p=0.00, respectively). Conclusions: Our data suggest that, irrespective of symptoms, early scheduled follow-up ERCP for patients who are at a high risk of recurrence is effective and safe.

Abstract

Background/Aims: To investigate the effi cacy of early scheduled follow-up endoscopic retrograde cholangiopancreatography (ERCP) after common bile duct (CBD) stone removal. Methods: Patients who underwent endoscopic CBD stone removal and who had at least one risk factor for stone recurrence were enrolled. Six months after complete clearance of the CBD, patients underwent follow-up ERCP at an ambulatory care center, irrespective of symptoms. Results: The incidence of symptoms and cholangitis at follow-up ERCP was signifi cantly lower in Group A (ERCP at 6 months after stone removal) than that in Group B (ERCP at >6 months) (14.3%vs 71.4%, p=0.00; 9.5% vs 33.3%, p=0.02, respectively). However, the recurrence rates of CBD stones were not different between Groups A and B (33.3% vs 47.6%). When comparing the subgroups, Group AR (stone recurrence in Group A)displayed signifi cantly fewer symptoms and lesser cholangitis and spent fewer days in the hospital than did Group BR (stone recurrence in Group B) (21.4% vs 70%, p=0.02; 14.3% vs 60%, p=0.02; 2.43±1.87 vs 6.10±3.35, p=0.00, respectively). Conclusions: Our data suggest that, irrespective of symptoms, early scheduled follow-up ERCP for patients who are at a high risk of recurrence is effective and safe.

참고문헌 (25)

  1. Hammarström LE, "Long-term follow-up after endoscopic treatment of bile duct calculi in cholecystectomized patients", World J Surg, 20, pp.272~276 (1996)
  2. Bergman JJ, "Long-term followup after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age", Gastrointest Endosc, 44, pp.643~649 (1996)
  3. Sugiyama M, "Follow-up of more than 10 years after endoscopic sphincterotomy for choledocholithiasis in young patients", Br J Surg, 85, pp.917~921 (1998)
  4. Prat F, "Biliary symptoms and complications more than 8 years after endoscopic sphincterotomy for choledocholithiasis", Gastroenterology, 110, pp.894~899 (1996)
  5. Sugiyama M, "Risk factors predictive of late complications after endoscopic sphincterotomy for bile duct stones: longterm (more than 10 years) follow-up study", Am J Gastroenterol, 97, pp.2763~2767 (2002)
  6. Keizman D, "Recurrent symptomatic common bile duct stones after endoscopic stone extraction in elderly patients", Gastrointest Endosc, 64, pp.60~65 (2006)
  7. Keizman D, "An angulated common bile duct predisposes to recurrent symptomatic bile duct stones after endoscopic stone extraction", Surg Endosc, 20, pp.1594~1599 (2006)
  8. Ueno N, "Prognostic factors for recurrence of bile duct stones after endoscopic treatment by sphincter dilation", Gastrointest Endosc, 58, pp.336~340 (2003)
  9. Ohashi A, "Risk factors for recurrent bile duct stones after endoscopic papillary balloon dilation: long-term follow-up study", Dig Endosc, 21, pp.73~77 (2009)
  10. 천영국, "Identification of risk factors for stone recurrence after endoscopic treatment of bile duct stones", EUROPEAN JOURNAL OF GASTROENTEROLOGY HEPATOLOGY, 18(5), pp.461~464, LIPPINCOTT WILLIAMS WILKINS
  11. Costamagna G, "Long-term follow-up of patients after endoscopic sphincterotomy for choledocholithiasis, and risk factors for recurrence", Endoscopy, 34, pp.273~279 (2002)
  12. Kim DI, "Risk factors for recurrence of primary bile duct stones after endoscopic biliary sphincterotomy", Gastrointest Endosc, 54, pp.42~48 (2001)
  13. Lai KH, "Do patients with recurrent choledocholithiasis after endoscopic sphincterotomy benefit from regular follow-up", Gastrointest Endosc, 55, pp.523~526 (2002)
  14. Kohn GP, "Endoscopic management of recurrent primary bile duct stones", ANZ J Surg, 78, pp.579~582 (2008)
  15. Bergman JJ, "Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones", Lancet, 349, pp.1124~1129 (1997)
  16. Ochi Y, "Comparing the treatment outcomes of endoscopic papillary dilation and endoscopic sphincterotomy for removal of bile duct stones", J Gastroenterol Hepatol, 14, pp.90~96 (1999)
  17. Arnold JC, "Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study", Endoscopy, 33, pp.563~567 (2001)
  18. Fujita N, "Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trial", Gastrointest Endosc, 57, pp.151~155 (2003)
  19. Disario JA, "Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones", Gastroenterology, 127, pp.1291~1299 (2004)
  20. Tanaka S, "Endoscopic papillary balloon dilation and endoscopic sphincterotomy for bile duct stones: longterm outcomes in a prospective randomized controlled trial", Gastrointest Endosc, 59, pp.614~618 (2004)
  21. Barkun AN, "Useful predictors of bile duct stones in patients undergoing laparoscopic cholecystectomy. McGill Gallstone Treatment Group", Ann Surg, 220, pp.32~39 (1994)
  22. Irie H, "Pitfalls in MR cholangiopancreatographic interpretation", Radiographics, 21, pp.23~37 (2001)
  23. Mehta SN, "Magnetic resonance cholangiopancreatography", Gastrointest Endosc Clin N Am, 7, pp.247~270 (1997)
  24. Geenen DJ, "The role of surveillance endoscopic retrograde cholangiopancreatography in preventing episodic cholangitis in patients with recurrent common bile duct stones", Endoscopy, 30, pp.18~20 (1998)
  25. Sugiyama M, "Endoscopic retreatment of recurrent choledocholithiasis after sphincterotomy", Gut, 53, pp.1856~1859 (2004)

이 간행물의 다른 논문 (19건)